Delivery Order SPE2DB22D3501-SPE2DB26FTK19
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,277.55 to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials on August 8, 2025, with completion targeted for August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,786.95 to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials on October 30, 2025, with completion expected by October 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, serves the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,104.76 to AmerisourceBergen Drug Corp for the supply of Barhemsys 10 mg/4 mL vials on June 1, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under the vendor's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials totaling $1,870.98, with an ultimate completion date of October 28, 2025. This firm fixed-price, competitively awarded delivery order was issued on October 27, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Barhemsys 5 mg/2 ml vials with a ceiling value of $1,198.52. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 million and extends through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a $2,221.96 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 5 mg/2 ml vials on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,159.02, is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $1,462.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of December 13, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,118.90, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $2,554.97 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 10 mg/4 ml vials on October 17, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. BARHEMSYS (amisulpride) is an atypical antipsychotic medication used in clinical settings to treat...